{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:56:04Z","timestamp":1777600564724,"version":"3.51.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,6]]},"DOI":"10.7759\/cureus.61820","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T15:43:58Z","timestamp":1717688638000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case Report of MuSK Antibody-Positive Myasthenia Gravis"],"prefix":"10.7759","author":[{"given":"Dinusha","family":"Gayathri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanika","family":"Nandasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamini","family":"Pathirana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00660","article-title":"Musk-associated myasthenia gravis: clinical features and management","volume":"11","author":"Rodolico C","year":"2020","unstructured":"Rodolico C, Bonanno C, Toscano A, Vita G. Musk-associated myasthenia gravis: clinical features and management. Front Neurol. 2020, 11:660. 10.3389\/fneur.2020.00660","journal-title":"Front Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13518","article-title":"Myasthenia gravis with antibodies to MuSK: an update","volume":"1412","author":"Evoli A","year":"2018","unstructured":"Evoli A, Alboini PE, Damato V, Iorio R, Provenzano C, Bartoccioni E, Marino M. Myasthenia gravis with antibodies to MuSK: an update. Ann N Y Acad Sci. 2018, 1412:82-89. 10.1111\/nyas.13518","journal-title":"Ann N Y Acad Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia ME","year":"2006","unstructured":"Farrugia ME, Robson MD, Clover L, et al.. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain. 2006, 129:1481-492. 10.1093\/brain\/awl095","journal-title":"Brain"},{"key":"ref4","article-title":"Myasthenia gravis patients with anti-MuSK antibodies","volume":"33","author":"Zagar M","year":"2009","unstructured":"Zagar M, Vranjes D, Sostarko M, Vogrinc Z, Bili\u0107 E, Cepe MT. Myasthenia gravis patients with anti-MuSK antibodies. Coll Antropol. 2009, 33:1151-1154.","journal-title":"Coll Antropol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.052415","article-title":"The features of myasthenia gravis with autoantibodies to MuSK","volume":"76","author":"Lavrnic D","year":"2005","unstructured":"Lavrnic D, Losen M, Vujic A, et al.. The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Amp Psychiatry. 2005, 76:1099-1102. 10.1136\/jnnp.2004.052415","journal-title":"J Neurol Neurosurg Amp Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.03.020","article-title":"MuSK-antibody-positive myasthenia gravis in a South Asian population","volume":"284","author":"Chang T","year":"2009","unstructured":"Chang T, Gunaratne P, Gamage R, Riffsy MT, Vincent A. MuSK-antibody-positive myasthenia gravis in a South Asian population. J Neurol Sci. 2009, 284:33-35. 10.1016\/j.jns.2009.03.020","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia","volume":"78","author":"D\u00edaz-Manera J","year":"2012","unstructured":"D\u00edaz-Manera J, Mart\u00ednez-Hern\u00e1ndez E, Querol L, et al.. Long-lasting treatment effect of rituximab in MuSK myasthenia. Neurology. 2012, 78:189-193. 10.1212\/WNL.0b013e3182407982","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147%2FNDT.S358851","article-title":"Efficacy and safety of low-dose rituximab in anti-Musk myasthenia gravis patients: a retrospective study","volume":"3","author":"Meng X","year":"2022","unstructured":"Meng X, Zeng Z, Wang Y, et al.. Efficacy and safety of low-dose rituximab in anti-Musk myasthenia gravis patients: a retrospective study. Neuropsychiatr Dis Treat. 2022, 3:953-964. 10.2147%2FNDT.S358851","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli A","year":"2003","unstructured":"Evoli A, Tonali PA, Padua L, et al.. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain. 2003, 126:2304-2311. 10.1093\/brain\/awg223","journal-title":"Brain"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/255703-a-case-report-of-musk-antibody-positive-myasthenia-gravis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T15:44:03Z","timestamp":1717688643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/255703-a-case-report-of-musk-antibody-positive-myasthenia-gravis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.61820","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,6]]}}}